Sukanta Roy

DEVELOPMENT OF MESOPOROUS NANOPARTICLES FOR ORAL DRUG DELIVERY TO TREAT VISCERAL LEISHMANIASIS (Utility Patent) OFFICIAL JOURNAL OF THE PATENT OFFICE Apr 2024 Abstract :The present invention relates to the developing mesoporous nanoparticles for oral drug delivery to combat visceral leishmaniasis (VL). VL, caused by Leishmania parasites, lacks effective vaccines and faces challenges in chemotherapy, including drug resistance and side effects. Mesoporous silica nanoparticles (MSNs) offer promising drug delivery solutions due to their stability, biocompatibility, and large surface area. By encapsulating anti-leishmanial drugs within MSNs… Show more Abstract :The present invention relates to the developing mesoporous nanoparticles for oral drug delivery to combat visceral leishmaniasis (VL). VL, caused by Leishmania parasites, lacks effective vaccines and faces challenges in chemotherapy, including drug resistance and side effects. Mesoporous silica nanoparticles (MSNs) offer promising drug delivery solutions due to their stability, biocompatibility, and large surface area. By encapsulating anti-leishmanial drugs within MSNs, we aim to enhance drug efficacy, minimize side effects, and overcome drug resistance. Our research explores the feasibility of MSNs as a cost-effective and less toxic approach for managing VL, potentially improving treatment outcomes and accessibility, especially in resource-limited settings.No. of Pages : 16 No. of Claims : 1 Show less

DEVICE TO DEVELOP DISSOLVING MICRONEEDLES FOR THE TREATMENT OF DIABETES MELLITUS (International Design Patent) Comptroller-General of Patents, Designs and Trade Marks Intellectual Property Office Apr 2024 International Design Classification:Version: 14-2023Class: 24 MEDICAL AND LABORATORY EQUIPMENTSubclass: 02 MEDICAL INSTRUMENTS, INSTRUMENTS AND TOOLS FORLABORATORY USE

IMPLANTABLE DEVICE FOR CONTINUOUS MONITORING OF GLUCOSE AND INSULIN DELIVERY (Indian Design Patent) Indian Patent Office, Govt. of India Apr 2024 Certified that the design of which a copy is annexed hereto has been registered as ofthe number and date given above in class 24-01 in respect of the application of suchdesign to IMPLANTABLE DEVICE FOR CONTINUOUS MONITORING OF GLUCOSE ANDINSULIN DELIVERY

Certificate of Registration of Design (Indian Design Patent) Indian Patent Office, GOI Mar 2024 BASKET TYPE DISSOLUTION APPARATUSFOR FLOATING DRUG DELIVERY SYSTEM

DEVICE FOR THE TREATMENT OF NEURODEGENERATIVE DISEASE FOR CONTINUOUS DRUG DELIVERY Comptroller-General of Patents, Designs and Trade Marks Intellectual Property Office, UK Feb 2024 DEVICE FOR THE TREATMENT OF NEURODEGENERATIVE DISEASE FORCONTINUOUS DRUG DELIVERYInternational Design Classification:Version: 14-2023Class: 24 MEDICAL AND LABORATORY EQUIPMENTSubclass: 01 APPARATUS AND EQUIPMENT FOR DOCTORS, HOSPITALSAND LABORATORIES

INSTRUMENT FOR LIPOSOMAL DRUG DELIVERY FOR THE TREATMENT OF PARKINSON'S DISEASE General of Patents, Designs and Trade Marks Intellectual Property Office Feb 2024 Certificate of Registration for a UK DesignDesign number: 6346294Grant date: 21 February 2024Registration date: 12 February 2024

FORMULATION OF MORINGA OLEIFERA IN THE TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE PUBLICATION OF THE PATENT OFFICE, ISSUE NO. 03/2024; DATE: 19/01/2024, IN Jan 2024 The present invention relates to the polyherbal tablet formulation designed for the treatment and prevention of liver diseases, particularly nonalcoholic fatty liver disease. The composition encompasses bioactive compounds from Moringa oleifera, Chrysanthemum, Piper Nigreum, and Terminalia Arjuna, along with flavonoids, antioxidants, and essential nutrients. The method involves meticulous extraction using ethanol, while pre-formulation studies ensure optimal powder characteristics. Dry… Show more The present invention relates to the polyherbal tablet formulation designed for the treatment and prevention of liver diseases, particularly nonalcoholic fatty liver disease. The composition encompasses bioactive compounds from Moringa oleifera, Chrysanthemum, Piper Nigreum, and Terminalia Arjuna, along with flavonoids, antioxidants, and essential nutrients. The method involves meticulous extraction using ethanol, while pre-formulation studies ensure optimal powder characteristics. Dry granulation is employed for tablet preparation, offering advantages in stability and cost-effectiveness. Evaluation studies confirm the tablets' visual, mechanical, and dissolution attributes, demonstrating their suitability for therapeutic use. The in-vitro drug release study highlights the tablets' controlled release profile. Show less

CERTIFICATE OF APPRECIATION Shree Dhanvantri Pharmacy College, Kim,Surat. Nov 2021 Sharing Valuable Knowledge on- "BA/BE Studies Under a Regulatory Nutshell" as a guest speaker.

CERTIFICATE OF HONOUR Lexstructor Legal News & Journal Publication House Jun 2020 This is certify that the Webinar conducted by Lexstructor on 'Impact ofCOVID-19 on the Patent Laws in India and Trade related Aspects onPotential Drugs' as held on June 28, 2020, was honoured with the valuable presence of our esteemed panelist and guest speaker.